Exhibit Hall

moderated by Sara White, MD, MS

Hands-on demonstrations

• Michael Soulen, MD, FSIR, FCIRSE
• Nicholas Fidelman, MD
• Irene Bargellini, MD, Prof
• Nishita Kothary, MD
• Juan Gimenez, MD
• Diana C. Dinh, MD, MPH
• Shilpa Reddy, MD
• Nadine Abi-Jaoudeh, MD
• Gregory Nadolski, MD
• Daniel Sze, MD, PhD
• Kashayar Farsad, MD, PhD
• Zach Berman, MD
• Julius Chapiro, MD, PhD

SIO Meets SITC: Beyond Liver (300 Level Education), 
moderated by Rony Avritscher, MD, FSIR, and Tulia C. Bruno, PhD

• Immunoscoring and TLS as a Biomarker of Response to Local Therapy, presented by Tullia C. Bruno, PhD
• Local Approaches to Overcoming Barriers in Cell-based Immunotherapy, presented by Jason Chiang, MD, PhD
• Development and Applications of Personalized Antitumoral Approaches
• Consideration for Stromal Imaging Biomarkers During Locoregional Treatments presented by Rony Avritscher, MD, FSIR
• Biomarkers of Tumor Microenvironment Barriers in Endovascular Therapy presented by Adam Stevens, PhD

OMD Tumor Board [Non-Hepatic] (200 Level Education),
moderated by Alexis Kelekis, MD, PhD, FCIRSE, FSIR, and David Breen, MD, FRCR

• Alda Tam, MD
• Robert Liddell, MD
• Alexandra Hotca-Cho, MD
• Dimitrios Filippiadis, MD, PhD, MSc, EBIR
• Michael Rutenberg, MD, PhD

Emerging Non-Thermal Ablation: Clinical Applications (300 Level Education),
moderated by Paul Laeseke, MD, PhD, and Marwan Moussa, MD

• Limitations of Thermal Ablation, presented by Erica Knavel Koepsel, MD
• IRE: Role in Cancer Care, presented by Man-Deuk Kim, MD, PhD, FSIR
• Current Status, Data, and Limitations of Histotripsy, presented by Mishal Mendiratta-Lala, MD
• Electrochemotherapy in Palliation, presented by Roberto Luigi Cazzato, MD, PhD
• PEF in Advanced Lung Cancer: Where are We? presented by William Moore, MD

Scientific Oral Abstracts (200 Level Education),
moderated by Christos Georgiades, MD, PhD, and Nicholas Fidelman, MD

• Lactate Dehydrogenase Inhibition During Transarterial Embolization Alters Growth of Target and Non-target HCC Tumors, presented by Ryan Baron, Medical Student (MS3)
• Comparison of Delivered and Absorbed Doses in Hepatocellular Carcinoma Patients Treated with Yttrium-90 Radiation Segmentectomy Using Resin Microspheres, presented by Mahmoud Odeh, MD
• 3D Vision Transformer Model for Prediction of Post-TACE Milan Criteria Status Using MRI Data, presented by Tej Mehta, MD
• Baseline Protein Levels Can Predict the Outcome After CT-guided High-Dose-Rate Brachytherapy of Colorectal Liver Metastases, presented by Matthias Stechele, MD
• Cholangiocarcinoma Treated with Yttrium-90 Radioembolization: Histopathologic Tumor Necrosis and Surgical Outcomes, presented by Qian Yu, MD
• Comparative Outcomes of Y90 Radioembolization and Transarterial Chemoembolization in Hepatocellular Carcinoma in Patients with Portal Vein Thrombosis : A Real-World Multicenter Cohort Study, presented by Chris Hsu, Medical Student
• PROACTIF:  Final Results from the Largest, Prospective HCC Real World Study using Yttrium-90 (Y90) Glass, presented by Etienne Garin, Professor

Locally Advanced Pancreatic Cancer: Adding the Local Approach (300 Level Education),
presented by William S. Rilling, MD, FSIR, Govindarajan Narayanan, MD, FSIR, and Kai-Wen Huang MD, MS, PhD, FASTA

• State of the Art Optimal Chemotherapy [mFolfirinox / Gem-nabPac] and Radiotherapy Consolidation, presented by Jennifer Valerin, MD, PhD
• Understanding the Difficult TME of LAPC, presented by Nadine Abi-Jaoudeh, MD
• IRE, Panfire-2 and Crossfire: What Have We Learned? presented by Hester J. Scheffer, MD
• Emerging Locoregional Technologies and Energies, presented by Martijn R. Meijerink, MD, PhD, FCIRSE
• Adjunctive Intra-arterial Approaches, presented by Paula Novelli, MD, FSIR

Industry Product Theatre

• Presented by Sirtex (Chatham Ballroom A)
• Presented by Varian, a Siemens Company (Chatham Ballroom B)

Discovery Theatre - Abstract Presentations,
moderated by Christos Georgiades, MD, PhD, and Isabel G. Newton, MD, PhD

• A Machine Learning Approach to Optimal Lesion Selection for Tumor Infiltrating Lymphocyte (TIL) Harvest in Advanced Melanoma, presented by Ajith Antony, MBBS, MD
• Ablation Confirmation in the Lung: An A0 Primer on Intraprocedural Guidance and Practice-Building Value, presented by Kevin Williams, BS
• Pre-Treatment Angiographic Analysis for Y90 Radioembolization in Recurrent Glioblastoma, presented by Delmarie M. Rivera Rodriguez, BS
• Assessment of Minimum Ablative Margin as a Predictor of Local Tumor Control in Soft Tissue Sarcomas Treated with Cryoablation, presented by Iman Ahmed, Current Medical Student, B.S.A.
• Top 10 Nerve Blocks Every Interventional Oncologist Should Know, presented by Jacqueline Brenner, BS
• Yttrium-90 Radioembolization in the Management of Intrahepatic Cholangiocarcinoma: Effectiveness and Safety Outcomes from Multicenter Study, presented by Mohammad Arabi, MD
• Target Trial Emulation: A Comparison of Resection, Ablation, and TARE for Early-Stage HCC – A Real-World Analysis, presented by Zohaa Faiz, MD

Metastatic Liver Session: mCRC and mNET (200 Level Education),
moderated by Nicholas Fidelman, MD, and Constantinos Sofocleous, MD, PhD, FSIR, FCIRSE

• mNET: Intersociety Guideline Update presented by Nicholas Fidelman, MD
• mNET: Current Role of y90? presented by Ghassan El-Haddad, MD
• Assessment of FLR Function: How? presented by David C. Madoff, MD
• Optimal Strategies for Venous Deprivation? presented by Jose Hugo Luz, MD, PhD, SOBRICE, FCIRSE, EBIR
• In Light of COLLISION: Optimal Approach to Bilobar Disease - IR Perspective, presented by Martijn R. Meijerink, MD, PhD
• In Light of COLLISION: Optimal Approach to Bilobar Disease - Surgeons Perspective Cases, presented by Kevin Soares, MD, MS

• Critical Role of Surgical Oncology, presented by Matthew Goodwin, MD, PhD
• State of the Art Palliative Radiation and SBRT presented by Meena Bedi, MD, MS
• Multidisciplinary Tumor Board, moderated by Jack Jennings, MD, PhD and Steven Yevich, MD, MPH

BCLC Update and Multifocal Disease,
moderated by Irene Bargellini, MD, and Rony Avritscher, MD, FSIR

• What are the Important Changes of the 2025 BCLC Update? presented by Ted Yanagihara, MD, PhD
• Optimal Locoregional Therapy Selection in the BCLC Update, presented by Riad Salem, MD, MBA
• Moderated Case Discussion for Downstaging and Disease Control for Multifocal HCC, presented by Kelvin Hong, MD, William Rilling, MD, FSIR, Irene Bargellini, MD, Rony Avritscher, MD, FSIR, and Riad Salem, MD, MBA

Saturday Soiree Social Event*

Additional registration required

Private Practice Forum: New Arenas (200 Level Education),
moderated by Jason R. Levy, MD, FSIR, and Juan C. Camacho, MD

• Business Case to Clients and Strategy for Building IO in the Hospital Based Setting, presented by Jason R. Levy, MD, FSIR
• Business Case for Building IO in an OBL Setting, presented by Charles Nutting, DO, FSIR 
• Thyroid Ablation for Primary Thyroid Cancer, presented by Juan C. Camacho, MD
• Breast Cryoablation: Current Indications and Technical Updates and Payment Models, presented by Kenneth Tomkovich, MD, FSIR
• Roundtable Discussion

Evidence-Based Illustrative Case Review (200 Level Education),
moderated by Nicholas Fidelman, MD, Roberto Luigi Cazzato, MD, PhD, and Charles Y. Kim, MD

• Case 1: Lymphatics, presented by Saebeom Hur, MD, PhD
• Case 2: Thyroid, presented by Wei-Che Lin, Prof, MD, PhD
• Case 3: Difficult mCRC, presented by Stephen Hunt, MTR, MD, PhD, FSIR
• Case 4: Adrenal, presented by Ahmad Parvinian, MD
• Case 5: Sarcoma / Soft Tissue, presented by Roberto Luigi Cazzato, MD, PhD
• Case 6: Vascular Emergencies in IO, presented by Charles Y. Kim, MD
• Case 7: T1b RCC, presented by Greg Laimer, MD, PhD